Rachel B. Salit

Rachel B. Salit is an Associate Professor in the Clinical Research Division at Fred Hutch Cancer Center and in the Division of Hematology and Oncology at the University of Washington School of Medicine. She practices at Fred Hutch Cancer Center - South Lake Union and Fred Hutch Cancer Center at UW Medical Center – Montlake, specializing in hematopoietic stem cell transplantation and myeloproliferative diseases.

Dr. Salit received her M.D. from Loyola University Stritch School of Medicine, completed her residency at the University of Maryland, and pursued a fellowship in Hematology-Oncology at the National Institutes of Health. She is board certified in Medical Oncology, Hematology, and Internal Medicine by the American Board of Internal Medicine.

Dr. Salit's research focuses on improving outcomes for patients undergoing stem cell transplant for myelofibrosis. Her work includes investigating pre-transplant ruxolitinib and optimizing alternative donor options such as haploidentical and cord blood transplants. She is also dedicated to enhancing cancer survivorship by developing strategies to improve patients' return to work transition following cancer treatment. Her clinical expertise spans hematopoietic stem cell transplantation, myeloproliferative diseases, and alternative donor transplant approaches.

Analysis of Dr. Salit's recent publications reveals a strong focus on myelofibrosis treatment and stem cell transplantation. Her work spans clinical guidelines development, molecular markers for transplantation decisions, and improving quality of life for cancer survivors. She frequently collaborates with international working groups to establish best practices in hematologic malignancies.

Dr. Salit has contributed to several National Comprehensive Cancer Network (NCCN) guidelines, including those for myeloproliferative neoplasms and systemic mastocytosis. Her research has been published in high-impact journals including The Lancet Haematology, Blood Advances, and Biology of Blood and Marrow Transplantation.

As a clinician-researcher, Dr. Salit bridges the gap between laboratory discoveries and patient care, focusing on practical interventions that improve both survival outcomes and quality of life for patients with hematologic malignancies. Her work on financial toxicity and return-to-work strategies addresses critical but often overlooked aspects of cancer survivorship.